$SCYX
SCYNEXIS INC Stock $scyx

$scyx Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000117825317000007 Filed on May 08, 2017

Income Statement

Concept	2017 Q2	2017 Q1	2016 Q1
Revenue	$64.00K	$64.00K	$64.00K
YoY Change	0.0%	0.0%	-1.54%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.361M	$2.060M	$2.533M
YoY Change	41.12%	-18.67%	14.62%
% of Gross Profit
Research & Development	$4.448M	$4.020M	$4.743M
YoY Change	-33.2%	-15.24%	25.24%
% of Gross Profit
Depreciation & Amortization	$40.00K	$1.000K	$3.000K
YoY Change	300.0%	-66.67%	-99.07%
% of Gross Profit
Operating Expenses	$6.809M	$6.080M	$7.276M
YoY Change	-18.28%	-16.44%	21.33%
Operating Profit	-$6.745M	-$6.016M	-$7.212M
YoY Change	-18.42%	-16.58%	21.58%
Interest Expense	$360.0K	$345.0K	$0.00
YoY Change			-100.0%
% of Operating Profit
Other Income/Expense, Net	$2.546M	$1.147M	$28.00K
YoY Change	1718.57%	3996.43%	2700.0%
Pretax Income	-$4.200M	-$4.870M	-$7.180M
YoY Change	-48.34%	-32.17%	21.06%
Income Tax
% Of Pretax Income
Net Earnings	-$4.199M	-$4.869M	-$7.184M
YoY Change	-48.34%	-32.22%	12.53%
Net Earnings / Revenue	-6560.94%	-7607.81%	-11225.0%
Basic Earnings Per Share		-$0.19	-$0.52
Diluted Earnings Per Share	-$1.628M	-$0.25	-$0.52
COMMON SHARES
Basic Shares Outstanding	25.80M shares	25.36M	13.91M shares
Diluted Shares Outstanding		25.56M	13.91M shares

Balance Sheet

Concept	2017 Q2	2017 Q1	2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$49.30M	$54.90M	$38.00M
YoY Change	-1.99%	44.47%	37.68%
Cash & Equivalents	$7.450M	$19.91M	$38.02M
Short-Term Investments	$41.90M	$35.00M
Other Short-Term Assets	$24.00K	$138.0K	$0.00
YoY Change	-60.0%		-100.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$50.85M	$55.59M	$39.92M
YoY Change	-3.57%	39.25%	15.49%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$652.0K	$730.0K	$429.0K
YoY Change	53.05%	70.16%	1240.63%
Total Long-Term Assets	$981.0K	$1.065M	$760.0K
YoY Change	24.81%	40.13%	162.98%
TOTAL ASSETS
Total Short-Term Assets	$50.85M	$55.59M	$39.92M
Total Long-Term Assets	$981.0K	$1.065M	$760.0K
Total Assets	$51.84M	$56.66M	$40.68M
YoY Change	-3.16%	39.27%	16.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.738M	$2.044M	$1.380M
YoY Change	52.99%	48.12%	52.82%
Accrued Expenses	$1.329M	$1.057M	$2.574M
YoY Change	-54.33%	-58.94%	-15.88%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.349M
YoY Change
Total Short-Term Liabilities	$4.673M	$3.358M	$5.041M
YoY Change	3.32%	-33.39%	-23.52%
LONG-TERM LIABILITIES
Long-Term Debt	$13.10M	$14.35M	$0.00
YoY Change
Other Long-Term Liabilities	$2.400M	$5.400M	$600.0K
YoY Change	-52.94%	800.0%	-73.91%
Total Long-Term Liabilities	$13.10M	$14.35M	$600.0K
YoY Change	156.92%	2292.0%	-73.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.673M	$3.358M	$5.041M
Total Long-Term Liabilities	$13.10M	$14.35M	$600.0K
Total Liabilities	$20.18M	$23.12M	$5.637M
YoY Change	109.13%	310.18%	-24.02%
SHAREHOLDERS EQUITY
Retained Earnings	-$189.3M	-$185.1M	-$157.3M
YoY Change	14.39%	17.63%	26.98%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$31.66M	$33.53M	$35.04M
YoY Change
Total Liabilities & Shareholders Equity	$51.84M	$56.66M	$40.68M
YoY Change	-3.16%	39.27%	16.71%

Cashflow Statement

Concept	2017 Q2	2017 Q1	2016 Q1
OPERATING ACTIVITIES
Net Income	-$4.199M	-$4.869M	-$7.184M
YoY Change	-48.34%	-32.22%	12.53%
Depreciation, Depletion And Amortization	$40.00K	$1.000K	$3.000K
YoY Change	300.0%	-66.67%	-99.07%
Cash From Operating Activities	-$7.380M	-$6.772M	-$8.960M
YoY Change	-17.91%	-24.42%	97.05%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$2.000K	$14.00K
YoY Change		-85.71%	-91.81%
Acquisitions
YoY Change
Other Investing Activities	-$6.970M	-$12.16M
YoY Change	-44.11%
Cash From Investing Activities	-$6.970M	-$12.16M	-$14.00K
YoY Change	-44.15%	86778.57%	-91.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$3.277M	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.880M	3.187M	$5.000K
YoY Change	-91.18%	63640.0%	-94.74%
NET CHANGE
Cash From Operating Activities	-7.380M	-6.772M	-$8.960M
Cash From Investing Activities	-6.970M	-12.16M	-$14.00K
Cash From Financing Activities	1.880M	3.187M	$5.000K
Net Change In Cash	-12.47M	-15.75M	-$8.969M
YoY Change	7693.75%	75.58%	94.01%
FREE CASH FLOW
Cash From Operating Activities	-$7.380M	-$6.772M	-$8.960M
Capital Expenditures	$0.00	$2.000K	$14.00K
Free Cash Flow	-$7.380M	-$6.774M	-$8.974M
YoY Change	-17.91%	-24.52%	90.21%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q1	dei	Amendment Flag AmendmentFlag	false
CY2017Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017Q1	dei	Document Period End Date DocumentPeriodEndDate	2017-03-31
CY2017Q1	dei	Document Type DocumentType	10-Q
CY2017Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001178253
CY2017Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	25798862	shares
CY2017Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2017Q1	dei	Entity Registrant Name EntityRegistrantName	SCYNEXIS INC
CY2016Q4	scyx	Accrued Researchand Development Expense Current AccruedResearchandDevelopmentExpenseCurrent	318000	USD
CY2017Q1	scyx	Accrued Researchand Development Expense Current AccruedResearchandDevelopmentExpenseCurrent	596000	USD
CY2017Q1	scyx	Additional Milestone Payments Maximum AdditionalMilestonePaymentsMaximum	2300000	USD
CY2016Q1	scyx	Deferred Offering Costs Incurred But Not Yet Paid DeferredOfferingCostsIncurredButNotYetPaid	25000	USD
CY2017Q1	scyx	Deferred Offering Costs Incurred But Not Yet Paid DeferredOfferingCostsIncurredButNotYetPaid	0	USD
CY2016Q1	scyx	Deferred Offering Costs Reclassified To Additional Paid In Capital DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital	0	USD
CY2017Q1	scyx	Deferred Offering Costs Reclassified To Additional Paid In Capital DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital	10000	USD
CY2013Q3	scyx	Deferred Revenue Recognition Period DeferredRevenueRecognitionPeriod	P70M
CY2017Q1	scyx	Derivative Fair Value Gain Loss From Mark To Market Adjustment DerivativeFairValueGainLossFromMarkToMarketAdjustment	1523000	USD
CY2016Q1	scyx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	0	USD
CY2017Q1	scyx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-5000	USD
CY2017Q1	scyx	Number Of License Agreements NumberOfLicenseAgreements	2	Agreement
CY2016Q4	scyx	Prepaid Researchand Development Expenses Current PrepaidResearchandDevelopmentExpensesCurrent	153000	USD
CY2017Q1	scyx	Prepaid Researchand Development Expenses Current PrepaidResearchandDevelopmentExpensesCurrent	121000	USD
CY2016Q1	scyx	Researchand Development Expense Gross ResearchandDevelopmentExpenseGross	4962000	USD
CY2017Q1	scyx	Researchand Development Expense Gross ResearchandDevelopmentExpenseGross	4039000	USD
CY2016Q1	scyx	Researchand Development Income Reimbursement ResearchandDevelopmentIncomeReimbursement	219000	USD
CY2017Q1	scyx	Researchand Development Income Reimbursement ResearchandDevelopmentIncomeReimbursement	19000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2192000	USD
CY2017Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2044000	USD
CY2016Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	730000	USD
CY2017Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	203000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1268000	USD
CY2017Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1057000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	214918000	USD
CY2017Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	218567000	USD
CY2017Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	396000	USD
CY2016Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	300000	USD
CY2016Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	274000	USD
CY2017Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	400000	USD
CY2017Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	396000	USD
CY2016Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
CY2017Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	100000	USD
CY2016Q4	us-gaap	Assets Assets	59792000	USD
CY2017Q1	us-gaap	Assets Assets	56655000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	59327000	USD
CY2017Q1	us-gaap	Assets Current AssetsCurrent	55590000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46985000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38016000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35656000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19908000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-8969000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-15748000	USD
CY2016Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	14033	shares
CY2017Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	14033	shares
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	7080921	shares
CY2017Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	8087041	shares
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24609411	shares
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25536533	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24609411	shares
CY2017Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25536533	shares
CY2016Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	24000	USD
CY2017Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	25000	USD
CY2016Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	345000	USD
CY2017Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	335000	USD
CY2016Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	25000	USD
CY2017Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	20000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	257000	USD
CY2017Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	257000	USD
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	378000	USD
CY2017Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	314000	USD
CY2016Q1	us-gaap	Depreciation Depreciation	3000	USD
CY2017Q1	us-gaap	Depreciation Depreciation	1000	USD
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.52
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.52
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	22000	USD
CY2017Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6000	USD
CY2016Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2017Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2016Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2017Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1523000	USD
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	6601000	USD
CY2017Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	5078000	USD
CY2017Q1	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	34991000	USD
CY2017Q1	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	35000	USD
CY2017Q1	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	70000	USD
CY2017Q1	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	35000000	USD
CY2017Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	34956000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	186000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-359000	USD
CY2016Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-64000	USD
CY2017Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-64000	USD
CY2016Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	477000	USD
CY2017Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	549000	USD
CY2016Q1	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	-1809000	USD
CY2017Q1	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	0	USD
CY2016Q1	us-gaap	Interest Expense InterestExpense	0	USD
CY2017Q1	us-gaap	Interest Expense InterestExpense	345000	USD
CY2016Q1	us-gaap	Interest Income Other InterestIncomeOther	28000	USD
CY2017Q1	us-gaap	Interest Income Other InterestIncomeOther	69000	USD
CY2016Q1	us-gaap	Interest Paid InterestPaid	0	USD
CY2017Q1	us-gaap	Interest Paid InterestPaid	345000	USD
CY2016Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	0	USD
CY2017Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	100000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	24973000	USD
CY2017Q1	us-gaap	Liabilities Liabilities	23122000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	59792000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	56655000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3717000	USD
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3358000	USD
CY2016Q1	us-gaap	License And Services Revenue LicenseAndServicesRevenue	64000	USD
CY2017Q1	us-gaap	License And Services Revenue LicenseAndServicesRevenue	100000	USD
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	14252000	USD
CY2017Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	14352000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3187000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12163000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8960000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6772000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-7184000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-4869000	USD
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-7184000	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3277000	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	5000	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	18000	USD
CY2013Q3	us-gaap	Proceeds From License Fees Received ProceedsFromLicenseFeesReceived	1500000	USD
CY2016Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	0	USD
CY2017Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	6000000	USD
CY2016Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2017Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2016Q1	us-gaap	Profit Loss ProfitLoss	-7184000	USD
CY2017Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-6392000	USD
CY2016Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	28000	USD
CY2017Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1147000	USD
CY2016Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	233000	USD
CY2016Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	200000	USD
CY2017Q1	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	300000	USD
CY2017Q1	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	252000	USD
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	7276000	USD
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	6080000	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7212000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6016000	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	413000	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	182000	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	231000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	198000	USD
CY2017Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	252000	USD
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	41000	USD
CY2017Q1	us-gaap	Other Assets Current OtherAssetsCurrent	138000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	120000	USD
CY2017Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	730000	USD
CY2016Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	71000	USD
CY2017Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	93000	USD
CY2016Q1	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	0	USD
CY2017Q1	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	108000	USD
CY2016Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	USD
CY2017Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	18161000	USD
CY2016Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14000	USD
CY2017Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2017Q1	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	741000	USD
CY2017Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	691000	USD
CY2016Q4	us-gaap	Prepaid Insurance PrepaidInsurance	243000	USD
CY2017Q1	us-gaap	Prepaid Insurance PrepaidInsurance	87000	USD
CY2016Q1	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	28000	USD
CY2017Q1	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	60000	USD
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13905613	shares
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25364429	shares
CY2017Q1	us-gaap	Profit Loss ProfitLoss	-4869000	USD
CY2016Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	111000	USD
CY2017Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4743000	USD
CY2017Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4020000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-180123000	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-185059000	USD
CY2016Q1	us-gaap	Revenues Revenues	64000	USD
CY2017Q1	us-gaap	Revenues Revenues	64000	USD
CY2016Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2533000	USD
CY2017Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2060000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	32000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1819444	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2770029	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.52
CY2016Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	1819444	shares
CY2017Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	2770029	shares
CY2016Q4	us-gaap	Short Term Investments ShortTermInvestments	22930000	USD
CY2017Q1	us-gaap	Short Term Investments ShortTermInvestments	34991000	USD
CY2017Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	17000	USD
CY2017Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3170000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	34819000	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	33533000	USD
CY2016Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	6601000	USD
CY2017Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	5078000	USD
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13905613	shares
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25562027	shares
CY2017Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:italic;">Concentration of Credit Risk</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Financial instruments, which potentially expose the Company to concentrations of credit risk, consist principally of cash on deposit and cash equivalents held with one bank which exceed FDIC insured limits. Ongoing credit evaluations of the customer’s financial condition are performed and independent credit ratings for the associated bank are reviewed by the Company and collateral is not required. The Company's money market fund investment (recognized as cash and cash equivalents) is with what the Company believes to be a high quality issuer. The Company has not experienced any losses in such account.</font></div></div>
CY2017Q1	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:48px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-style:italic;font-weight:normal;text-decoration:none;">Revenue Recognition and Deferred Revenue</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The Company has entered into collaboration arrangements in exchange for non-refundable upfront payments and consideration as services are performed. These arrangements include multiple elements, such as the sale of licenses and the provision of services. Under these arrangements, the Company also is entitled to receive development milestone payments and royalties in the form of a designated percentage of product sales. The Company classifies non-refundable upfront payments, milestone payments and royalties received under collaboration and licensing agreements as revenues within its statements of operations because the Company views such activities as being central to its business operations.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Revenue is recognized when all of the following conditions are met: (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred or services have been rendered, (iii) fees are fixed or determinable, and (iv) collection of fees is reasonably assured. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">When entering into an arrangement, the Company first determines whether the arrangement includes multiple deliverables and is subject to accounting guidance in ASC subtopic 605-25, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:italic;">Multiple-Element Arrangements</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">. If the Company determines that an arrangement includes multiple elements, it determines whether the arrangement should be divided into separate units of accounting and how the arrangement consideration should be measured and allocated among the separate units of accounting. An element qualifies as a separate unit of accounting when the delivered element has stand-alone value to the customer. The Company’s arrangements do not include a general right of return relative to delivered elements. Any delivered elements that do not qualify as separate units of accounting are combined with other undelivered elements within the arrangement as a single unit of accounting. If the arrangement constitutes a single combined unit of accounting, the Company determines the revenue recognition method for the combined unit of accounting and recognizes the revenue over the period from inception through the date the last deliverable within the single unit of accounting is delivered.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Non-refundable upfront license fees are recorded as deferred revenue and recognized into revenue on a straight-line basis over the estimated period of the Company’s substantive performance obligations. If the Company does not have substantive performance obligations, the Company recognizes non-refundable upfront fees into revenue through the date the deliverable is satisfied. Analyzing the arrangement to identify deliverables requires the use of judgment and each deliverable may be an obligation to deliver services, a right or license to use an asset, or another performance obligation. In arrangements that include license rights and other non-contingent deliverables, such as participation in a steering committee, these deliverables do not have stand-alone value because the non-contingent deliverables are dependent on the license rights. That is, the non-contingent deliverables would not have value without the license rights, and only the Company can perform the related services. Upfront license rights and non-contingent deliverables, such as participation in a steering committee, do not have stand-alone value as they are not sold separately and they cannot be resold. In addition, when non-contingent deliverables are sold with upfront license rights, the license rights do not represent the culmination of a separate earnings process. As such, the Company accounts for the license and the non-contingent deliverables as a single combined unit of accounting. In such instances, the license revenue in the form of non-refundable upfront payments is deferred and recognized over the applicable relationship period, which historically has been the estimated period of the Company’s substantive performance obligations or the period the rights granted are in effect. The Company recognizes contingent event-based payments under license agreements when the payments are received. The Company has not received any royalty payments to date.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The Company will recognize a milestone payment when earned if it is substantive and the Company has </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">no</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> ongoing performance obligations related to the milestone. A milestone payment is considered substantive if it: 1) is commensurate with either the Company’s performance to achieve the milestone or the enhanced value of the delivered item as a result of a specific outcome from the Company’s performance to achieve the milestone; 2) relates solely to past performance; and 3) is reasonable relative to all of the deliverables and payment terms, including other potential milestone consideration, within the arrangement.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Amounts received prior to satisfying all revenue recognition criteria are recorded as deferred revenue in the accompanying balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The Company’s deferred revenue includes non-refundable upfront payments received under certain licensing and collaboration arrangements that contain substantive performance obligations that the Company is providing over respective defined service or estimated relationship periods. Such non-refundable upfront payments are recognized over these defined service or estimated relationship periods.</font></div></div>

Files In Submission

Name	View Source	Status
0001178253-17-000007-index-headers.html	Edgar Link	pending
0001178253-17-000007-index.html	Edgar Link	pending
0001178253-17-000007.txt	Edgar Link	pending
0001178253-17-000007-xbrl.zip	Edgar Link	pending
exhibit121-33117.htm	Edgar Link	pending
exhibit311-33117.htm	Edgar Link	pending
exhibit312-33117.htm	Edgar Link	pending
exhibit321-33117.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
scyx-20170331.xml	Edgar Link	completed
scyx-20170331.xsd	Edgar Link	pending
scyx-20170331_cal.xml	Edgar Link	unprocessable
scyx-20170331_def.xml	Edgar Link	unprocessable
scyx-20170331_lab.xml	Edgar Link	unprocessable
scyx-20170331_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SCYX
SCYNEXIS INC Stock $scyx

2017 Q2 Form 10-Q Financial Statement

#000117825317000007 Filed on May 08, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCYX SCYNEXIS INC Stock $scyx

2017 Q2 Form 10-Q Financial Statement

#000117825317000007 Filed on May 08, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCYX
SCYNEXIS INC Stock $scyx